JP2008501670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008501670A5 JP2008501670A5 JP2007514086A JP2007514086A JP2008501670A5 JP 2008501670 A5 JP2008501670 A5 JP 2008501670A5 JP 2007514086 A JP2007514086 A JP 2007514086A JP 2007514086 A JP2007514086 A JP 2007514086A JP 2008501670 A5 JP2008501670 A5 JP 2008501670A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- compound according
- ome
- nme
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0412553.0 | 2004-06-04 | ||
| GBGB0412553.0A GB0412553D0 (en) | 2004-06-04 | 2004-06-04 | Therapeutic agents for the treatment of bone conditions |
| PCT/GB2005/002043 WO2005118528A2 (en) | 2004-06-04 | 2005-05-23 | Aryl alkyl sulfonamides as therapeutic agents for the treatment of bone conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008501670A JP2008501670A (ja) | 2008-01-24 |
| JP2008501670A5 true JP2008501670A5 (https=) | 2008-07-03 |
| JP5042015B2 JP5042015B2 (ja) | 2012-10-03 |
Family
ID=32696703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007514086A Expired - Fee Related JP5042015B2 (ja) | 2004-06-04 | 2005-05-23 | 骨状態を治療するための治療薬としてのアリールアルキルスルホンアミド類 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7964643B2 (https=) |
| EP (1) | EP1756046B1 (https=) |
| JP (1) | JP5042015B2 (https=) |
| AT (1) | ATE451350T1 (https=) |
| DE (1) | DE602005018203D1 (https=) |
| DK (1) | DK1756046T3 (https=) |
| GB (1) | GB0412553D0 (https=) |
| SI (1) | SI1756046T1 (https=) |
| WO (1) | WO2005118528A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0705400D0 (en) * | 2007-03-21 | 2007-05-02 | Univ Aberdeen | Therapeutic compounds andm their use |
| WO2009096198A1 (ja) * | 2008-02-01 | 2009-08-06 | Pharma Ip Limited Liability Intermediary Corporations | 新規ビアリール誘導体 |
| GB0817208D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
| GB0817207D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
| GB201311361D0 (en) | 2013-06-26 | 2013-08-14 | Pimco 2664 Ltd | Compounds and their therapeutic use |
| AU2015367528B2 (en) | 2014-12-17 | 2020-05-14 | Pimco 2664 Limited | N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and their therapeutic use |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1046220B (de) | 1956-04-21 | 1958-12-11 | Bayer Ag | Verfahren zur Herstellung von Monoazofarbstoffen und deren Metallkomplexverbindungen |
| IL118325A0 (en) * | 1995-05-25 | 1996-10-31 | Pont Merck And Pharmaceutical | Integrin receptor antagonists and pharmaceutical compositions containing them |
| WO1997016433A1 (en) | 1995-10-30 | 1997-05-09 | Smithkline Beecham Corporation | Protease inhibitors |
| US5760028A (en) * | 1995-12-22 | 1998-06-02 | The Dupont Merck Pharmaceutical Company | Integrin receptor antagonists |
| WO1997033887A1 (en) | 1996-03-15 | 1997-09-18 | Du Pont Pharmaceuticals Company | Spirocycle integrin inhibitors |
| JP2000515153A (ja) * | 1996-07-22 | 2000-11-14 | モンサント カンパニー | チオールスルホンアミド メタロプロテアーゼインヒビター |
| IL129344A0 (en) * | 1996-11-27 | 2000-02-17 | Du Pont Pharm Co | Novel integrin receptor antagonists |
| US6214834B1 (en) | 1997-03-28 | 2001-04-10 | Dupont Pharmaceuticals Company | Integrin inhibitor prodrugs |
| IL132630A0 (en) * | 1997-05-08 | 2001-03-19 | Smithkline Beecham Corp | Protease inhibitors |
| PT877019E (pt) * | 1997-05-09 | 2002-05-31 | Hoechst Ag | Acidos diaminocarboxilicos substituidos |
| DE19719621A1 (de) | 1997-05-09 | 1998-11-12 | Hoechst Ag | Sulfonylaminocarbonsäuren |
| US6291425B1 (en) * | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| YU47200A (sh) | 1998-01-23 | 2002-11-15 | Aventis Pharma Deutschland Gmbh. | Novi derivati sulfonamida kao inhibitori koštane resorpcije i kao inhibitori ćelijske adhezije |
| JP4750272B2 (ja) | 1998-02-04 | 2011-08-17 | ノバルティス アーゲー | マトリックス分解メタロプロテイナーゼを阻害するスルホニルアミノ誘導体 |
| JPH11246527A (ja) | 1998-03-02 | 1999-09-14 | Shionogi & Co Ltd | Ｍｍｐ−８阻害剤 |
| EP0960882A1 (en) * | 1998-05-19 | 1999-12-01 | Hoechst Marion Roussel Deutschland GmbH | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| MXPA02009309A (es) * | 2000-03-21 | 2003-03-12 | Procter & Gamble | Inhibidores de las metaloproteasas n-sustituidas que contienen cadenas laterales carboxiclicas. |
| WO2001090077A1 (en) * | 2000-05-19 | 2001-11-29 | Guilford Pharmaceuticals, Inc. | Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses |
| AU2002228316A1 (en) * | 2001-01-29 | 2002-08-12 | Insight Strategy And Marketing Ltd | Carbazole derivatives and their uses as heparanase inhibitors |
| JPWO2002074298A1 (ja) | 2001-03-21 | 2004-07-08 | 小野薬品工業株式会社 | Ｉｌ−６産生阻害剤 |
| CN101284773A (zh) | 2001-08-09 | 2008-10-15 | 小野药品工业株式会社 | 羧酸衍生物及以它为活性成分的药剂 |
| GB0126157D0 (en) | 2001-10-31 | 2002-01-02 | Univ Aberdeen | Therapeutic compounds |
| US20050227994A1 (en) | 2002-03-27 | 2005-10-13 | Shionogi & Co., Ltd. | Decomposition inhibitor for extracellular matrix of cartilage |
| MXPA05002571A (es) | 2002-09-04 | 2005-09-08 | Schering Corp | Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina. |
| DE602004010514T2 (de) | 2003-05-07 | 2008-11-27 | The University Court Of The University Of Aberdeen, Aberdeen | Ketone und reduzierte ketone als therapeutische mittel zur behandlung von knochenerkrankungen |
| WO2005058808A1 (en) * | 2003-12-15 | 2005-06-30 | Japan Tobacco Inc. | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
-
2004
- 2004-06-04 GB GBGB0412553.0A patent/GB0412553D0/en not_active Ceased
-
2005
- 2005-05-23 EP EP05746683A patent/EP1756046B1/en not_active Expired - Lifetime
- 2005-05-23 AT AT05746683T patent/ATE451350T1/de not_active IP Right Cessation
- 2005-05-23 WO PCT/GB2005/002043 patent/WO2005118528A2/en not_active Ceased
- 2005-05-23 US US11/628,084 patent/US7964643B2/en active Active
- 2005-05-23 JP JP2007514086A patent/JP5042015B2/ja not_active Expired - Fee Related
- 2005-05-23 SI SI200530922T patent/SI1756046T1/sl unknown
- 2005-05-23 DK DK05746683.1T patent/DK1756046T3/da active
- 2005-05-23 DE DE602005018203T patent/DE602005018203D1/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008525409A5 (https=) | ||
| ES2842123T3 (es) | Purificación de tenofovir alafenamida y sus intermedios | |
| EP4473980A3 (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancers | |
| JP2004511462A5 (https=) | ||
| ES2229030T3 (es) | Procedimiento de preparacion de 9-(2-(dietilfosfonometoxi)etil)-adenina. | |
| JP2008501670A5 (https=) | ||
| ES2469847T3 (es) | Derivados de tiazol y su uso como antagonistas del receptor P2Y12 | |
| BR102014008928A2 (pt) | métodos para a preparação de análogos de nucleotídeos antivirais | |
| JP2012532143A (ja) | Ｎ４−（２，２−ジメチル−４−［（二水素ホスホノオキシ）メチル］−３−オキソ−５−ピリド［１，４］オキサジン−６−イル）−５−フルオロ−ｎ２−（３，４，５−トリメトキシフェニル）−２，４−ピリミジンジアミン二ナトリウム塩の合成 | |
| EP3872064B1 (en) | Fluorinated imide salt compound and surfactant | |
| JP2017526726A5 (https=) | ||
| JP2006511476A5 (https=) | ||
| JP2001525322A5 (https=) | ||
| JP2017137291A5 (https=) | ||
| JP2010522152A5 (https=) | ||
| JP2004501940A5 (https=) | ||
| EA201800118A1 (ru) | Фосфорамидатное нуклеозидное пролекарство для лечения вирусных и раковых заболеваний, способы его получения и использования | |
| WO2019188200A1 (ja) | スルファミン酸リチウムの製造方法及び新規スルファミン酸リチウム | |
| US10040809B2 (en) | Method for preparing tris(trialkylsilyl)phosphine | |
| JP2017531663A5 (https=) | ||
| ES2754603T3 (es) | Procedimiento para la preparación de fosfinatos | |
| JP2019512490A5 (https=) | ||
| JP2008069182A5 (https=) | ||
| AP543A (en) | Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives. | |
| JP2008543874A5 (https=) |